Philippe Decruyenaere

Biomarker tail genes in blood plasma cell-free RNA enable accurate detection of prostate cancer

Annelien Morlion (UGent) , Philippe Decruyenaere (UGent) , Kathleen Schoofs (UGent) , Jasper Anckaert (UGent) , Nickolas Johns Ramirez (UGent) , Justine Nuytens (UGent) , Eveline Vanden Eynde (UGent) , Kimberly Verniers (UGent) , Celine Everaert (UGent) , Guy Brusselle (UGent) , et al.

(2026) CANCER RESEARCH. In Cancer Research 86(7, Supplement S).

Add to list

Journal Article
A2
open access

Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controls

Annelien Morlion (UGent) , Philippe Decruyenaere (UGent) , Kathleen Schoofs (UGent) , Jasper Anckaert (UGent) , Nickolas Johns Ramirez (UGent) , Justine Nuytens (UGent) , Eveline Vanden Eynde (UGent) , Kimberly Verniers (UGent) , Celine Everaert (UGent) , Guy Brusselle (UGent) , et al.

(2026) COMMUNICATIONS MEDICINE. 6(1).

Add to list

Effective front-line treatment of osteosclerotic myeloma with POEMS syndrome with daratumumab, lenalidomide and dexamethasone : a case report and literature review

Chiel Gharakhani, Alexander Soetens, Wouter Huysse (UGent) , Philippe Decruyenaere (UGent) and Nicolas Kint (UGent)

(2026) ACTA CLINICA BELGICA. 81(1). p.39-44

Add to list

PhD Thesis

Exploring the cell-free transcriptome as a biomarker source in non-Hodgkin lymphoma

Philippe Decruyenaere (UGent)

(2025)

Add to list

Journal Article
A1
open access

Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling

The exRNAQC Consortium, Jasper Anckaert (UGent) , Francisco Avila Cobos (UGent) , Anneleen Decock (UGent) , Philippe Decruyenaere (UGent) , Jill Deleu (UGent) , Katleen De Preter (UGent) , Olivier De Wever (UGent) , Jilke De Wilde (UGent) , Bert Dhondt, et al.

(2025) NATURE COMMUNICATIONS. 16(1).

Add to list

Journal Article
A1
open access

Subpar reporting of pre‐analytical variables in RNA‐focused blood plasma studies

Céleste Van Der Schueren, Philippe Decruyenaere (UGent) , Francisco Avila Cobos (UGent) , Johanna Bult, Jill Deleu (UGent) , Lydia Dipalo, Hetty Helsmoortel (UGent) , Eva Hulstaert, Annelien Morlion (UGent) , Elena Ramos Varas (UGent) , et al.

(2025) MOLECULAR ONCOLOGY. 19(7). p.1968-1978

Add to list

Exploring the cell-free transcriptome as biomarker source in IgM gammopathies : new insights from the Fondazione Italiana Linfomi 'BIO-WM' trial

Philippe Decruyenaere (UGent) , Daniela Drandi, Kimberly Verniers (UGent) , Simone Ragaini, Jasper Anckaert (UGent) , Veronica Peri, Elisa Genuardi, Federica Cavallo, Luigi Marcheselli, Irene Dogliotti, et al.

(2024) BLOOD. In Blood 144(Supplement 1). p.3297-3298

Add to list

Research Data

Characterizing the cell-free transcriptome in a humanized DLBCL patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting

Philippe Decruyenaere (UGent) , Jo Vandesompele (UGent) , Willem Daneels (UGent) and Fritz Offner (UGent)

(2024)

Add to list

Journal Article
A1
open access

Therapy response monitoring in blood plasma from esophageal adenocarcinoma patients using cell-free DNA methylation profiling

Kathleen Schoofs (UGent) , Maísa Renata Ferro Dos Santos (UGent) , Jilke De Wilde (UGent) , Sofie Roelandt (UGent) , Sofie Van de Velde (UGent) , Philippe Decruyenaere (UGent) , Leander Meuris (UGent) , Olivier Thas (UGent) , Annouck Philippron, Lieven Depypere, et al.

(2024) SCIENTIFIC REPORTS. 14(1).

Add to list

Subpar reporting of pre-analytical variables in RNA-focused blood plasma studies

Céleste Van Der Schueren (UGent) , Philippe Decruyenaere (UGent) , Francisco Avila Cobos (UGent) , Johanna Bult, Jill Deleu (UGent) , Lydia Dipalo, Hetty Helsmoortel (UGent) , Eva Hulstaert, Annelien Morlion (UGent) , Elena Ramos Varas (UGent) , et al.

(2024) OncoPoint Symposium, 10th, Abstracts.

Academic Bibliography

Philippe Decruyenaere

Biomarker tail genes in blood plasma cell-free RNA enable accurate detection of prostate cancer

Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controls

Effective front-line treatment of osteosclerotic myeloma with POEMS syndrome with daratumumab, lenalidomide and dexamethasone : a case report and literature review

Exploring the cell-free transcriptome as a biomarker source in non-Hodgkin lymphoma

Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling

Subpar reporting of pre‐analytical variables in RNA‐focused blood plasma studies

Exploring the cell-free transcriptome as biomarker source in IgM gammopathies : new insights from the Fondazione Italiana Linfomi 'BIO-WM' trial

Characterizing the cell-free transcriptome in a humanized DLBCL patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting

Therapy response monitoring in blood plasma from esophageal adenocarcinoma patients using cell-free DNA methylation profiling

Subpar reporting of pre-analytical variables in RNA-focused blood plasma studies

Contents

Support

Contact